The Food and Drug Administration (FDA) reviewed 300 new drug applications between
1995 and 2000. Of the 163 that included a sex analysis, 11 drugs showed a> 40% difference …

Adverse drug reactions (ADRs) rank as one of the top 10 leading causes of death and
illness in developed countries. ADRs show differential features depending upon genotype …

Background Osteosarcoma is the most common primary bone malignancy. As a rare cancer,
population‐based studies remain small with limited information on finer demographic …

THE US CENSUS BUREAU PROJECTS that the US population will have increasing
numbers of women in the next decades and a greater proportion of the population will be …

OBJECTIVE: The aim of this article is to offer recommendations and rationale for gender-
specific antipsychotic treatment. METHOD: The author summarizes reviews of recent …

This chapter considers a range of conceptual, methodological, statistical, and substantive
issues in the study of sex differences in the development of psychopathology. It considers …

The association of an individual's genetic makeup with their response to drugs is referred to
as pharmacogenomics. By understanding the relationship between genetic variants and …

Six second-generation antipsychotics (SGAs), aripiprazole, clozapine, olanzapine,
quetiapine, risperidone and ziprasidone, are currently US FDA approved. The aim of this …

Objective Mining the data contained within Electronic Health Records (EHRs) can potentially
generate a greater understanding of medication effects in the real world, complementing …

With the incidence and prevalence of lymphoid neoplasms increasing, a comparison of
survival patterns by subtype may provide critical clues for improving the disease burden. We …